IRWD MEXC RealStocks
Own real IRWD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:10:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Ironwood Pharmaceuticals, Inc. - (IRWD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.85, with a market capitalization of $796.30M and a P/E ratio of 5.39. Over the past 52 weeks, its price has ranged from $2.85 to $5.78. This page covers its latest market performance, valuation, price trends and company information.
$796.30M | |
$4.83 | |
$4.99 | |
$4.75 | |
$4.87 | |
3.16M | |
2.02M | |
5.39 | |
$5.78 | |
$2.85 | |
-- | |
-- |
Ironwood Pharmaceuticals, Inc. - (IRWD) is trading at $4.85 in after-hours trading as of 2026-11-12 22:04:00, unchanged from the regular-session close of $4.85.
After-hours trading shows how investors are pricing IRWD after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.
Over the past seven days, Ironwood Pharmaceuticals, Inc. - (IRWD) moved from $3.50 to $4.85, representing a gain of 38.43% ($1.34).
The stock traded between $3.40 and $4.99 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 3.75 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 68.0%
IRWD is currently trading at $4.85, placing it 68.0% of the way from its 52-week low of $2.85 to its 52-week high of $5.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 100 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Ironwood Pharmaceuticals, Inc. -.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Ironwood Pharmaceuticals, Inc. - (IRWD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IRWD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IRWD shares and USD.
IRWD Shares to USD
1.00 IRWD shares = 4.845 USD
Calculations are estimates based on the latest available price and are for reference only.